Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2013, Article ID 541689, 9 pages
http://dx.doi.org/10.1155/2013/541689
Clinical Study

Improved Hypertension Control with the Imidazoline Agonist Moxonidine in a Multinational Metabolic Syndrome Population: Principal Results of the MERSY Study

1Clinical Cardiology Institute A.L. Myasnikov FSI Russian Cardiology Scientific and Production Complex Ministry of Health, 3rd Cherepkovskaya No. 15, Moscow 121552, Russia
2Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, VIC 8008, Australia

Received 19 November 2012; Accepted 12 January 2013

Academic Editor: Eduardo Vera Tibiriçá

Copyright © 2013 Irina Chazova and Markus P. Schlaich. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Irina Chazova and Markus P. Schlaich, “Improved Hypertension Control with the Imidazoline Agonist Moxonidine in a Multinational Metabolic Syndrome Population: Principal Results of the MERSY Study,” International Journal of Hypertension, vol. 2013, Article ID 541689, 9 pages, 2013. https://doi.org/10.1155/2013/541689.